Caina Technology Co

Caina Technology Co EBITDA Margin

The EBITDA Margin of Caina Technology Co (301122.SZ) as of Nov 14, 2026 is 0.90 %. In the previous year, EBITDA Margin was 16.87 % — a change of -94.65% (lower).

EBITDA Margin

0.90 %

YoY

-94.65%

Last updated:

EBITDA Margin of Caina Technology Co is 2025 0.90 % . EBITDA Margin of Caina Technology Co was 2024 16.87 % . It decreases by -94.65% lower compared to the previous year.

The Caina Technology Co EBITDA Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA Margin
Date
EBITDA Margin
Jan 1, 2018
17.30 CNY
Jan 1, 2019
24.36 CNY
Jan 1, 2020
33.20 CNY
Jan 1, 2021
35.46 CNY
Jan 1, 2022
39.66 CNY
Jan 1, 2023
32.82 CNY
Jan 1, 2024
16.87 CNY
Jan 1, 2025
0.90 CNY
The Caina Technology Co EBITDA Margin history
YEAREBITDA MarginYoY
0.90 %-94.65%
16.87 %-48.58%
32.82 %-17.25%
39.66 %+11.83%
35.46 %+6.82%
33.20 %+36.28%
24.36 %+40.81%
17.30 %+26.99%
13.62 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Caina Technology Co Stock analysis

What does Caina Technology Co do? Caina Technology Co., Ltd. manufactures medical consumables including puncture needles, syringes, laboratory consumables, and masks. The company's main products are reusable copper base injection needles, aluminum base injection needles, disposable aluminum-plastic inlaid injection needles, safety blood collection needles, sheathed syringes, disposable Sterile syringes, petri dishes, and reagent tubes. Caina Technology exports its products to the United States, the United Kingdom, and the European Union, serving international markets with its medical supplies. The company generates revenue through the sale of its medical consumables to global healthcare providers and distributors. Its product range targets hospitals, clinics, and laboratories requiring reliable medical equipment. Caina Technology's focus on exporting to developed markets ensures steady demand for its high-quality, compliant medical products. Caina Technology's business model relies on manufacturing and exporting medical consumables to international customers. The firm's product portfolio includes specialized items like safety blood collection needles and sterile syringes, which are essential for healthcare facilities. By targeting key regions such as the United States, United Kingdom, and European Union, the company secures consistent sales channels for its medical supplies. Caina Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Caina Technology Co stock

EBITDA Margin of Caina Technology Co is 0.90 % in 2025.

EBITDA Margin of Caina Technology Co changed from 16.87 % to 0.90 %, representing a -94.65% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA Margin Caina Technology Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA Margin shows what percentage of revenue converts to EBITDA. It normalizes for depreciation and capital structure differences.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBITDA Margin's Caina Technology Co with sector peers and the industry average to assess whether it is attractive.

To evaluate EBITDA Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBITDA Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Caina Technology Co

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Caina Technology Co